Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
Funding will accelerate commercial launch of DefineMBC™SAN DIEGO--(BUSINESS WIRE)--Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last twelve months. T...
Source: pharmiweb.com
